Frontiers in Anxiety and Depression: Clinical and Pharmaceutical Perspectives скачать в хорошем качестве

Frontiers in Anxiety and Depression: Clinical and Pharmaceutical Perspectives

Freda Lewis-Hall, MD, surveyed the persistent unmet need in anxiety and depression treatment and her organization's efforts to address it through novel serotonergic pharmacology. Lewis-Hall emphasized that despite decades of therapeutic advancement, nearly half of the estimated 20 million patients with generalized anxiety disorder continued to experience inadequate symptom relief. She described Helus Pharma’s pipeline of novel serotonergic agonists—particularly HLP004 for GAD and HLP003 for major depressive disorder—as adjunctive therapies aimed at delivering durable, meaningful improvement for treatment-refractory patients. Dr Lewis-Hall is on the board of directors and is chair of the scientific committee for Helus Pharma See more on depression, anxiety, and psychopharmacology at https://www.psychiatrictimes.com/ #psychiatry #anxiety #depression #psychiatrictimes